Kelly McGlinchey
- Oncology top 5%
- Immunology top 10%
- Molecular Biology
- Hematology top 5%
- Physiology top 2%
- Co-authors
- Amy CamusoNicholas M. DurhamChristine FleflehKrista FagerDavid KanRobert A. KramerIvan InigoKathy Mulgrew
- Topics
- Immune Cell Function and Interaction (8 papers)Cancer Immunotherapy and Biomarkers (7 papers)Chronic Lymphocytic Leukemia Research (6 papers)
- Cited by
- PhysiologyOncologyHematology
- Partner nations
- United StatesJapanGermany
In The Last Decade
Kelly McGlinchey
27 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 71
- Oncology 603
- Immunology 258
- Molecular Biology 248
- Hematology 169
- Physiology 156
Countries citing papers authored by Kelly McGlinchey
This map shows the geographic impact of Kelly McGlinchey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly McGlinchey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly McGlinchey more than expected).
Fields of papers citing papers by Kelly McGlinchey
This network shows the impact of papers produced by Kelly McGlinchey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly McGlinchey. The network helps show where Kelly McGlinchey may publish in the future.
Co-authorship network of co-authors of Kelly McGlinchey
This figure shows the co-authorship network connecting the top 25 collaborators of Kelly McGlinchey. A scholar is included among the top collaborators of Kelly McGlinchey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly McGlinchey. Kelly McGlinchey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 19 | |
| 3 | 75 | |
| 4 | 59 | |
| 5 | 10 | |
| 6 | 1 | |
| 7 | 91 | |
| 8 | 51 | |
| 9 | 31 | |
| 10 | 229 | |
| 11 | 10 | |
| 12 | 83 | |
| 13 | 28 | |
| 14 | 113 | |
| 15 | BMS-354825 potently inhibits multiple selected oncogenic tyrosine kinases and possesses broad-spectrum antitumor activities in vitro and in vivo | 38 |
| 16 | 66 | |
| 17 | 22 | |
| 18 | 14 | |
| 19 | 5 | |
| 20 | 1 |
About Kelly McGlinchey
Kelly McGlinchey is a scholar working on Oncology, Genetics and Hematology, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Physiology (156 citations), Oncology (603 citations) and Hematology (169 citations). Kelly McGlinchey has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Amy Camuso, Nicholas M. Durham, Christine Flefleh, Krista Fager, David Kan, Robert A. Kramer, Ivan Inigo, Kathy Mulgrew, Stephen Castaneda and Richard Smykla. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.